Please assess the completion status of the following clinical trial:

Trial Title: Vitamin D Supplementation Requirement in Obese Subjects

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: TRIPLE
- Phase: None
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Healthy men or women between the ages of 18 and 70 years old who are enrolled in our Weight Management Program with baseline BMI \> 30 Kg/m2.~Exclusion Criteria:~* Pregnancy,~* Serum 25(OH)D level greater than 80 nmol/L,~* Hypercalcemia (serum calcium level greater than the upper limit of normal),~* Recent surgery or illness,~* Those with chronic use of medications that influence calcium/vitamin D metabolism such as anti-convulsants, lithium and steroids. Thiazide diuretics for hypertension will be acceptable.~* Subjects with sarcoidosis will be excluded.~* Those who do not qualify to participate in the Weight Management Program will be excluded. They include subjects with active substance abuse and unstable cardiac disease.

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: 70 Years
- Healthy Volunteers: f

Study Arms:
- Placebo (Type: PLACEBO_COMPARATOR): Half of subjects will be randomized to the placebo group.
- Vitamin D3 (Type: ACTIVE_COMPARATOR): This is the study group that receives Vitamin D supplementation.

Based on this trial design, predict the completion outcome and termination type (if applicable).